How to Administer Intravenous Amiodarone (IVPB)
Amiodarone must be administered as a slow infusion using a volumetric infusion pump—never as a rapid IV push—because rapid administration causes severe hypotension, bradycardia, and can lead to hepatocellular necrosis and acute renal failure. 1
Standard Dosing Protocol
Initial 24-Hour Loading Regimen
The FDA-approved dosing delivers approximately 1000 mg over the first 24 hours 1:
- Loading dose: 150 mg in 100 mL D5W infused over 10 minutes
- Slow infusion: 1 mg/min for 6 hours (360 mg)
- Maintenance infusion: 0.5 mg/min for the remaining 18 hours (540 mg)
Do not exceed an initial infusion rate of 30 mg/min 1
Breakthrough Arrhythmias
For recurrent VF or hemodynamically unstable VT during maintenance infusion:
- Give supplemental 150 mg bolus in 100 mL D5W over 10 minutes 1
- This slower infusion minimizes hypotension risk
Critical Administration Requirements
Equipment and Access
- Use a volumetric infusion pump (mandatory—drop counters can underdose by up to 30%) 1
- Administer through a central venous catheter whenever possible 1
- Use an in-line filter 1
Concentration Limits
For infusions >1 hour, do not exceed 2 mg/mL concentration unless using a central line 1. This is critical because:
- Concentrations >3 mg/mL cause high rates of peripheral vein phlebitis 1
- Concentrations ≤2.5 mg/mL are less irritating 1
- Central lines allow concentrations up to 6 mg/mL 1
Container Requirements
- Use glass or polyolefin bottles with D5W only for infusions >2 hours 1
- Do not use evacuated glass containers (causes precipitation) 1
- PVC tubing is acceptable (all clinical trials used PVC) but leaches plasticizers 1
Why Slow Infusion is Mandatory
Hemodynamic Consequences of Rapid Administration
The evidence is unequivocal that rapid bolus administration causes dangerous hemodynamic effects:
- Hypotension occurs in 16% of patients receiving IV amiodarone 2
- Bradycardia and heart block occur in 4.9% 2
- Rapid infusions at higher concentrations and rates than recommended have resulted in hepatocellular necrosis, acute renal failure, and death 1
The 2003 guidelines emphasize that if hypotension or bradycardia occur, you must discontinue the infusion or reduce the rate 2. Research from 1984 showed that patients with ejection fraction <0.35 experienced a 20% decrease in cardiac index after acute bolus administration 3.
Excipient-Related Toxicity
The standard formulation (Cordarone IV) contains polysorbate 80 and benzyl alcohol, both of which cause hypotension 4. A 2004 study demonstrated that rapid bolus of standard formulation produced significant decreases in mean arterial blood pressure lasting at least 2 hours, while an aqueous formulation without these excipients had better hemodynamic profiles 4. However, the aqueous formulation is not widely available, so the standard formulation must be given slowly.
Maintenance Therapy
After the first 24 hours:
- Continue 0.5 mg/min (720 mg per 24 hours) 1
- Can be continued for 2-3 weeks regardless of age, renal function, or left ventricular function 1
- May increase rate to achieve arrhythmia suppression 1
- Mean daily doses >2100 mg increase hypotension risk 1
Common Pitfalls to Avoid
- Never use drop counter infusion sets—they underdose by up to 30% 1
- Never give rapid IV push—causes life-threatening complications 1
- Never exceed 2 mg/mL concentration in peripheral lines for infusions >1 hour 1
- Never use evacuated glass containers for mixing 1
- Do not use in patients with second- or third-degree heart block without a pacemaker 2
Monitoring During Infusion
Watch closely for:
- Hypotension (most common adverse effect at 16%) 2
- Bradycardia and heart block (4.9%) 2
- If either occurs, stop or slow the infusion immediately 2
The 10-minute infusion for the 150 mg loading dose represents the minimum safe administration time to minimize hypotension 2, 1. This is not negotiable—faster administration risks severe hemodynamic compromise and organ damage.